Drug intelligence / Profile preview

(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid

Development stage: Unknown
Modality: Small Molecules

Overview

(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is an experimental small molecule belonging to the indole-3-acetic acid derivatives, characterized by an indole ring linked at the C3 position to an acetic acid moiety and further substituted with a mercapto group via an ethoxyimino linker. It is known to target interleukin-2, suggesting potential immunomodulatory activity. The compound has been studied structurally and biochemically but does not have established clinical use or approved indications[1][5][8].

Other names: (2R)-2-(1H-indol-3-yl)-2-[(2-sulfanylethoxy)amino]acetic acid(R)-1H-indol-3-yl[(2-sulfanylethoxy)amino]acetic acid

Targets

IL-2 (Interleukin 2)

Beyond the preview

Go deeper on (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid.

Explore the full profile